Drug class review on newer drugs for insomnia final report
Insomnia is a serious health problem that affects millions of people. Treatment involves behavioral changes, such as minimizing daily habits that interfere with sleep, and pharmacotherapy. The newer drugs for insomnia differ from each other in their pharmacokinetics, which could be expected to affec...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Portland, Or.
Oregon Health & Science University, Evidence-Based Practice Center
2006, c2006
|
| Series: | Drug class reviews
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Insomnia is a serious health problem that affects millions of people. Treatment involves behavioral changes, such as minimizing daily habits that interfere with sleep, and pharmacotherapy. The newer drugs for insomnia differ from each other in their pharmacokinetics, which could be expected to affect different aspects of insomnia. For example, drugs with a shorter half-life might be effective for sleep latency but less effective for sleep duration. The purpose of this review is to compare the effectiveness and harms of these newer drugs for treatment of insomnia |
|---|---|
| Item Description: | "July 2006." |
| Physical Description: | PDF file (90 p.) |